[Fluvoxamine. Study of treatment effect on a group of 189 hospitalized patients with depression].
The study of a sample of 189 inpatients with the diagnostic of Major Depressive Disorder (DSM III-R) treated with fluvoxamine showed: a good compromise efficacy/tolerance in 75% of cases; an interruption of treatment in 25% of cases, schematically divided in early gastric intolerance and in late resistance. 2.5% of manic switches have been observed and contribued, with this pattern of good results, to confirm the major antidepressant activity and good tolerance of fluvoxamine.
Peyre
F
F
Unité d'Investigations Cliniques Approfondies, C.H.S. Charles Perrens, Bordeaux.
Verdoux
H
H
Bourgeois
M
M
D001714:Bipolar Disorder / Q000139:chemically induced / Q000209:etiology; D003866:Depressive Disorder / Q000150:complications / Q000188:drug therapy*; D016666:Fluvoxamine / Q000009:adverse effects / Q000627:therapeutic use*; D006760:Hospitalization; D006801:Humans; D013997:Time Factors
D016666:Fluvoxamine
Fluvoxamine. Etude de l'effet du traitement sur un groupe de 189 déprimés hospitalisés.